Search Results - "Zhang, Jiasi Vicky"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms by Thokala, Radhika, Binder, Zev A., Yin, Yibo, Zhang, Logan, Zhang, Jiasi Vicky, Zhang, Daniel Y., Milone, Michael C., Ming, Guo-li, Song, Hongjun, O’Rourke, Donald M.

    Published in Frontiers in oncology (10-09-2021)
    “…Tumor heterogeneity is a key reason for therapeutic failure and tumor recurrence in glioblastoma (GBM). Our chimeric antigen receptor (CAR) T cell (2173 CAR T…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Selective removal of misfolded SOD1 delays disease onset in a mouse model of amyotrophic lateral sclerosis by Guan, Teng, Zhou, Ting, Zhang, Xiaosha, Guo, Ying, Yang, Chaoxian, Lin, Justin, Zhang, Jiasi Vicky, Cheng, Yongquan, Marzban, Hassan, Wang, Yu Tian, Kong, Jiming

    “…Background Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease. There is no cure currently. The discovery that mutations in the gene…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Single-cell RNA-seq-based proteogenomics identifies glioblastoma-specific transposable elements encoding HLA-I-presented peptides by Bonté, Pierre-Emmanuel, Arribas, Yago A, Merlotti, Antonela, Carrascal, Montserrat, Zhang, Jiasi Vicky, Zueva, Elina, Binder, Zev A, Alanio, Cécile, Goudot, Christel, Amigorena, Sebastian

    Published in Cell reports (Cambridge) (07-06-2022)
    “…We analyze transposable elements (TEs) in glioblastoma (GBM) patients using a proteogenomic pipeline that combines single-cell transcriptomics, bulk RNA…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes by Alanio, Cécile, Binder, Zev A, Chang, Renee B, Nasrallah, MacLean P, Delman, Devora, Li, Joey H, Tang, Oliver Y, Zhang, Logan Y, Zhang, Jiasi Vicky, Wherry, E John, O'Rourke, Donald M, Beatty, Gregory L

    Published in Cancer immunology research (01-07-2022)
    “…Glioblastoma (GBM) is an immunologically "cold" tumor characterized by poor responsiveness to immunotherapy. Standard of care for GBM is surgical resection…”
    Get more information
    Journal Article
  8. 8